03/21/2025
8:41 AM | Achilles Therapeutics (Filer)
| Form 15-12G | |
03/20/2025
4:30 PM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025
3:11 PM | Achilles Therapeutics (Filer)
| Form S-8 POS | |
03/19/2025
3:13 PM | Achilles Therapeutics (Filer)
| Form S-8 POS | |
03/19/2025
3:16 PM | Achilles Therapeutics (Filer)
| Form S-8 POS | |
03/11/2025
11:15 PM | Achilles Therapeutics (Filer)
| Form EFFECT | |
03/11/2025
6:00 AM | Achilles Therapeutics (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
03/11/2025
6:15 AM | Achilles Therapeutics (Filer)
| Form POS AM | |
03/03/2025
8:43 AM | Achilles Therapeutics (Subject)
Ali Iraj (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:52 AM | Achilles Therapeutics (Subject)
Coutts Robert William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
7:16 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ACHL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/18/2025
5:37 AM | Achilles Therapeutics (Subject)
Coutts Robert William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
4:02 PM | Achilles Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
11:48 AM | Achilles Therapeutics (Subject)
Ehmer Bernhard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2025
12:32 PM | Achilles Therapeutics (Subject)
Moses Edwin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:50 AM | Achilles Therapeutics (Subject)
BOESS CARSTEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:55 AM | Achilles Therapeutics (Subject)
Giordano Michael F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:39 AM | Achilles Therapeutics (Subject)
O'Neill Julie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
6:15 AM | Achilles Therapeutics (Subject)
Ali Iraj (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
1:06 PM | Achilles Therapeutics (Subject)
Quezada Sergio Andres (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
11:46 AM | Achilles Therapeutics (Subject)
Coutts Robert William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
5:06 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024
6:22 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
7:28 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
8:33 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
6:14 PM | Achilles Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
09/19/2024
6:17 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
7:04 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
6:00 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
4:15 PM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
6:44 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
7:12 AM | Achilles Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/04/2024
7:25 AM | Achilles Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:30 PM | Achilles Therapeutics (Subject)
Artal International S.C.A. (Filed by)
| Form SC 13G/A | |
Buy ACHL Stock Free ACHL Stock Alerts